NEWS
Institutional Subscription: Comprehensive Analyses to Enhance Your Global and Local Impact
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Binbing Yu
AstraZeneca, Sweden - Södertälje / Sweden
Others
AD Scientific Index ID: 4400042
-
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Binbing Yu's MOST POPULAR ARTICLES
1-)
Red cell distribution width and mortality in older adults: a meta-analysisKV Patel, RD Semba, L Ferrucci, AB Newman, LP Fried, RB Wallace, ...Journals of Gerontology Series A: Biomedical Sciences and Medical Sciences …, 20095192009
2-)
Total and cancer mortality after supplementation with vitamins and minerals: follow-up of the Linxian General Population Nutrition Intervention TrialYL Qiao, SM Dawsey, F Kamangar, JH Fan, CC Abnet, XD Sun, ...Journal of the National Cancer Institute 101 (7), 507-518, 20093762009
3-)
Comparability of segmented line regression modelsHJ Kim, MP Fay, B Yu, MJ Barrett, EJ FeuerBiometrics 60 (4), 1005-1014, 20042422004
4-)
Benefit/risk assessment for breast cancer chemoprevention with raloxifene or tamoxifen for women age 50 years or olderAN Freedman, B Yu, MH Gail, JP Costantino, BI Graubard, VG Vogel, ...Journal of Clinical Oncology 29 (17), 2327, 20112302011
5-)
Bias associated with self-report of prior screening mammographyKA Cronin, DL Miglioretti, M Krapcho, B Yu, BM Geller, PA Carney, ...Cancer Epidemiology and Prevention Biomarkers 18 (6), 1699-1705, 20091562009
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept